Finance

Lists
002603:SHE
Shijiazhuang Yiling Pharmaceuticl Co Ltd
CNยฅ15.50
+0.32%
(+0.050) 1D
Nov 17, 3:04:39โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002603...
Open
CNยฅ15.40
High
CNยฅ15.50
Low
CNยฅ15.12
Mkt. cap
25.81B
Avg. vol.
14.10M
Volume
13.05M
Dividend
5.16%
Quarterly dividend
CNยฅ0.20
Ex-dividend date
Jun 16, 2026
P/E ratio
18.74
52-wk high
CNยฅ21.10
52-wk low
CNยฅ14.22
EPS
CNยฅ0.83
Shares outstanding
1.67B
No. of employees
11K
Open
CNยฅ15.40
High
CNยฅ15.50
Low
CNยฅ15.12
Mkt. cap
25.81B
Avg. vol.
14.10M
Volume
13.05M
Dividend
5.16%
Quarterly dividend
CNยฅ0.20
Ex-dividend date
Jun 16, 2026
P/E ratio
18.74
52-wk high
CNยฅ21.10
52-wk low
CNยฅ14.22
EPS
CNยฅ0.83
Shares outstanding
1.67B
No. of employees
11K
News stories
From web sources and news partners
About Shijiazhuang Yiling Pharmaceuticl Co Ltd
CEO-
Employees11.3K
FoundedJun 16, 1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteyiling.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.96B
2.44B
1.63B
1.89B
Cost of goods sold
558.68M
974.60M
546.30M
624.49M
Cost of revenue
558.68M
974.60M
546.30M
624.49M
Research and development expenses
174.24M
173.79M
126.10M
149.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
748.27M
749.37M
538.30M
670.09M
Operating expense
965.99M
972.94M
692.33M
860.77M
Total operating expenses
1.52B
1.95B
1.24B
1.49B
Operating income
438.46M
492.24M
396.34M
408.38M
Other non operating income
-1.72M
-2.14M
-892.55K
-2.98M
EBT including unusual items
421.98M
489.10M
422.27M
405.73M
EBT excluding unusual items
437.85M
494.81M
400.21M
411.34M
Income tax expense
136.92M
80.49M
73.81M
67.02M
Effective tax rate
32.45%
16.46%
17.48%
16.52%
Other operating expenses
28.77M
42.45M
31.47M
35.74M
Net income
286.07M
408.85M
348.45M
338.63M
Net profit margin
14.57%
16.76%
21.31%
17.88%
Earnings per share
-
-
-
-
Interest and investment income
3.33M
5.07M
7.59M
3.55M
Interest expense
-302.73K
-361.45K
-212.85K
-222.28K
Net interest expenses
3.03M
4.71M
7.38M
3.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
592.20M
645.98M
556.92M
562.11M
Gain or loss from assets sale
887.25K
-
362.77K
-362.77K
Upcoming events
AI content may include mistakes. Learn more
Google apps